-
Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page
Why are so many leaving recently and where is everyone going?
- Thread starter anonymous
- Start date
-
- Tags
- None
The people I know that have left recently have been smart enough to wait until a great opportunity came along. Some have went to other oncology positions and some biologics.
People left because they had terrible managers and know one will do anything to change that. Others are leaving when they find positions, just watch. Turnover here is about 35% per year. Most I know of went to better oncology jobs.
“Recently”? Hahaha! This has been happening for decades.
Whats the deal with Jen Simier in FL. She always has openings. Is she bad news?
Law salary, no stock upside, shit bonus, company rep in the industry is a joke, horrible management (it doesn't deserve to be called leadership). Any questions?
Eisai is a very nice company, just my experience, but the drug is old. What can you do? Of course reps will switch to something new and higher pay.
I guess everything is relative. Like an airport Marriott is nice compared to the Motel 6, but it's a dump compared to a Four Seasons. Eisai is nice compared to Pfizer or J & J or Merck...I guess...is it nice compared to the good biotechs? Nah...